13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 43 holding rows worth $439,196,984.
- Accession
- 0001214659-24-002438
- Filer
- CIK 1482416
- Filed
- 2024-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 43 entries on the cover page, a total value of $439,196,984 stated on the cover page (in dollars after the unit check, H1), rows summing to $439,196,984 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,451,925 | $85,300,594 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 5,001,580 | $50,215,863 | dollars as filed | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 165,123 | $37,530,807 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 116,553 | $34,901,796 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 532,089 | $28,355,023 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 861,700 | $26,704,083 | dollars as filed | put |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 571,391 | $21,175,750 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 644,366 | $19,105,452 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 80,050 | $17,602,195 | dollars as filed | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 736,008 | $13,932,631 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 141,300 | $13,625,559 | dollars as filed | put |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 460,044 | $10,548,809 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 36,527 | $9,107,642 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 72,300 | $8,798,910 | dollars as filed | |
| NEOGEN CORP | 640491106 | COM | 427,000 | $8,586,970 | dollars as filed | put |
| HEALTHCARE SVCS GROUP INC | 421906108 | COM | 810,307 | $8,402,884 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,105,911 | $6,060,392 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 131,753 | $5,318,869 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 971,446 | $4,332,649 | dollars as filed | |
| Merrimack Pharmaceuticals Inc | 590328209 | Common / Ordinary Stock | 288,466 | $3,868,329 | dollars as filed | |
| HARPOON THERAPEUTICS INC | 41358P205 | COM | 297,936 | $3,387,532 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 3,588,427 | $3,008,896 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 246,036 | $2,364,406 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 251,532 | $2,200,905 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 635,969 | $2,054,180 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 163,400 | $1,869,296 | dollars as filed | put |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 163,363 | $1,792,092 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 320,394 | $1,368,082 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 280,000 | $1,316,000 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 689,352 | $1,254,621 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 33,007 | $1,174,389 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 200,076 | $928,353 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 150,000 | $906,000 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 121,672 | $784,784 | dollars as filed | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 97,616 | $411,940 | dollars as filed | |
| INOGEN INC | 45780L104 | COM | 52,794 | $289,839 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 400,000 | $172,020 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 130,000 | $148,200 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R200 | SPON ADS NEW | 254,150 | $132,692 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 102,049 | $120,418 | dollars as filed | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $21,642 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 30,741 | $15,315 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 12,808 | $175 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-24-002438 | this filing | 2024-02-13 | acceptance time not in the bulk data set |